RESLIZUMAB Pharmacologic Class Indexing
- Class set ID
- ede289f1-ae18-4f67-9724-96bf7b6b8022
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use CINQAIR safely and effectively. See full prescribing information for CINQAIR. CINQAIR ® (reslizumab) injection, for intravenous use Initial U.S. Approval: 2016 | Teva Respiratory, LLC | 20200229 | 14 |